A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes
Clinical trial NCT04353817 · COMPLETED
Trial details
- NCT number
- NCT04353817
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-19
- Primary completion
- 2021-05-17
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.